Back to search

University of British Columbia

The serum metabolome and breast cancer risk

Abstract

dc:description

Background: Metabolomics offers a promising approach to identifying biomarkers for timely intervention and enhanced screening for individuals at risk of breast cancer. In this nested case-control study, we used self-reported risk factors and prospectively collected blood samples to identify metabolites associated with breast cancer and develop predictive models to assess population risk profiles. Methods: Participants from two Canadian prospective cohorts, BC Generations Project and Alberta’s Tomorrow Project, completed baseline health and lifestyle questionnaires and donated blood samples at enrollment. 593 women who subsequently developed breast cancer cases were matched one-to-one with healthy controls based on cohort, age at blood collection, time of blood collection, and menopause status. Quadrupole time-of-flight mass spectrometry was used for untargeted metabolomics profiling of baseline serum samples. Logistic regression was used to estimate odds ratios corresponding to a one standard deviation increase of metabolite levels after adjusting for matching variables and selected health and lifestyle risk factors. Associations were also assessed for matched pairs with postmenopausal cancer, invasive ductal carcinoma, and hormone receptor-positive cancer. Five classifiers – lasso, random forest (RF), and partial least squares discriminant analysis (PLS-DA), and support vector machines (SVMs) with linear and radial basis functions – were used to develop risk prediction models. Results: 24 metabolites were significantly associated with risk of developing breast cancer, including 13 associated with decreased risk and 11 associated with increased risk. No associations were attenuated by more than 10% when adjusted for risk factors. Among the 24 metabolites, associations with postmenopausal breast cancer, invasive ductal carcinoma, and ER+/PR+ breast cancer were found for 10, 10, and 4 metabolites, respectively. Prediction models using these metabolites had moderate discrimination, with highest AUC of 0.63. Lasso and SVM with linear basis function outperformed the other three algorithms. Conclusion: Overall, our results suggest metabolomics data shows potential as breast cancer biomarkers. More studies are needed to confirm the identities of detected metabolites and validate their associations with breast cancer risk. Future analyses that incorporate larger sample sizes and longitudinal samples will further provide more insights into the metabolic mechanisms surrounding cancer development.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Population and Public Health
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Trinh, Huong Ly
Contributors dc:contributor
  • Bhatti, Parveen

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/88168

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Trinh, Huong Ly. The serum metabolome and breast cancer risk. master's thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/88168